Humankind Investments LLC Buys 2,400 Shares of Avantor, Inc. (NYSE:AVTR)

Humankind Investments LLC increased its stake in shares of Avantor, Inc. (NYSE:AVTR) by 27.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,234 shares of the company’s stock after acquiring an additional 2,400 shares during the quarter. Humankind Investments LLC’s holdings in Avantor were worth $237,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Avantor by 99.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after buying an additional 625 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of Avantor by 106.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock valued at $34,000 after buying an additional 830 shares in the last quarter. Global Retirement Partners LLC lifted its stake in shares of Avantor by 76.7% in the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after buying an additional 1,067 shares in the last quarter. UMB Bank n.a. lifted its stake in shares of Avantor by 56.3% in the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after buying an additional 1,074 shares in the last quarter. Finally, AlphaQuest LLC bought a new position in shares of Avantor in the fourth quarter valued at $65,000. 95.08% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have weighed in on AVTR. Stifel Nicolaus lowered shares of Avantor from a “buy” rating to a “hold” rating and dropped their price objective for the company from $26.00 to $14.00 in a research note on Monday, April 28th. Cowen downgraded shares of Avantor from a “buy” rating to a “hold” rating in a report on Monday, April 28th. Morgan Stanley downgraded shares of Avantor from an “overweight” rating to an “equal weight” rating in a report on Tuesday, April 29th. Barclays lowered their target price on shares of Avantor from $18.00 to $15.00 and set an “overweight” rating for the company in a report on Monday, April 28th. Finally, Raymond James reiterated an “outperform” rating and issued a $24.00 target price (down previously from $26.00) on shares of Avantor in a report on Monday, February 10th. Seven analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $18.88.

Avantor Stock Performance

NYSE AVTR opened at $12.03 on Monday. Avantor, Inc. has a 52-week low of $11.82 and a 52-week high of $28.00. The company has a 50-day simple moving average of $15.13 and a 200 day simple moving average of $18.89. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.70 and a current ratio of 1.07. The company has a market capitalization of $8.20 billion, a PE ratio of 11.57, a price-to-earnings-growth ratio of 1.55 and a beta of 1.09.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Friday, April 25th. The company reported $0.23 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.23. Avantor had a net margin of 10.49% and a return on equity of 12.17%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter last year, the company posted $0.22 earnings per share. The firm’s quarterly revenue was down 5.9% compared to the same quarter last year. On average, research analysts predict that Avantor, Inc. will post 1.06 EPS for the current year.

Insider Buying and Selling

In other Avantor news, Director Gregory L. Summe bought 25,000 shares of Avantor stock in a transaction dated Wednesday, May 7th. The stock was purchased at an average price of $12.00 per share, for a total transaction of $300,000.00. Following the completion of the purchase, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $600,000. This trade represents a 100.00% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Joseph R. Massaro bought 8,100 shares of Avantor stock in a transaction dated Tuesday, April 29th. The stock was acquired at an average price of $12.30 per share, with a total value of $99,630.00. Following the purchase, the director now directly owns 35,038 shares of the company’s stock, valued at approximately $430,967.40. This represents a 30.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.20% of the stock is currently owned by corporate insiders.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.